|
2024
|
Invention
|
Compositions for the effective treatment of vitamin c deficiency-related diseases and other condi... |
|
|
Invention
|
Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications th... |
|
|
Invention
|
Ready-to-use ascorbic acid compound compositions.
The invention described here provides ready-to... |
|
|
Invention
|
Tiotropium combination product compositions and related methods.
The present invention is direct... |
|
2023
|
Invention
|
Ophthalmic gel compositions of bimatoprost and timolol and associated methods. The present invent... |
|
|
Invention
|
Methods of treating ophthalmic conditions with enhanced penetration compositions of bimatoprost a... |
|
|
Invention
|
Enhanced penetration ophthalmic compositions of bimatoprost and timolol. The present invention pr... |
|
|
Invention
|
Formulations of pilocarpine and brimonidine compounds and related methods. The present invention ... |
|
|
Invention
|
Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methods. The pre... |
|
|
Invention
|
Low ph pilocarpine and brimonidine compound formulations and related methods. The present inventi... |
|
|
Invention
|
Pharmaceutically stable pilocarpine formulations with substantially reduced buffer content and re... |
|
|
Invention
|
Ophthalmologically suitable low pka buffer-containing pilocarpine compositions and related method... |
|
|
Invention
|
Stable pilocarpine formulations with modified buffer characteristics and related methods. Disclos... |
|
2022
|
Invention
|
Ready-to-use ascorbic acid compound compositions. The invention described here provides ready-to-... |
|
|
Invention
|
Methods of efficiently treating vitamin c deficiency-related diseases and other conditions. The i... |
|
|
Invention
|
Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications... |
|
|
Invention
|
Buffer- and chelator-free, stable ophthalmological compositions of ketorolac and phenylephrine an... |
|
|
Invention
|
Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketor... |
|
|
Invention
|
Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereof... |
|
|
Invention
|
Pharmaceutical compositions and methods utilizing neostigmine and an nk-1 antagonist for treating... |
|
|
Invention
|
Combination products of tobramycin compounds and dexamethasone compounds.
Disclosed herein are n... |
|
|
Invention
|
Methods for modulating conditions of the eye using novel latanoprost compound ophthalmic composit... |
|
|
Invention
|
Stable latanoprost compound ophthalmic compositions.
The present invention relates to an ophthal... |
|
|
Invention
|
Moxifloxacin and triamcinolone compositions and associated methods. Provided here are new ophthal... |
|
|
Invention
|
Limited particle size triamcinolone and moxifloxacin compositions and associated methods of use. ... |
|
|
Invention
|
Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods ... |
|
2021
|
Invention
|
Tobramycin compound conjugate formulations. Disclosed herein are compositions comprising tobramyc... |
|
|
Invention
|
Efficient tobramycin compound conjugate compositions. Disclosed herein are compositions comprisin... |
|
|
Invention
|
Tobramycin compound-copolymer conjugates and derivative compositions. Disclosed herein are compos... |
|
|
Invention
|
Glycopeptide antibiotics liquid formulations and methods and uses thereof. The invention relates ... |
|
|
Invention
|
Methods of efficiently reducing intraocular pressure. Disclosed herein are pharmacologically acce... |
|
|
Invention
|
Safe use of brinzolamide and brimonidine compositions with enhanced benzalkonium chloride content... |
|
|
Invention
|
Safe brinzolamide and brimonidine compositions with enhanced benzalkonium chloride content.
Disc... |
|
|
Invention
|
Efficient brinzolamide and brimonidine compositions.
Disclosed herein are pharmacologically acce... |
|
|
G/S
|
Pharmaceutical preparations, namely, general anesthetics, anti-infectives, antipsychotics, anti-i... |
|
|
Invention
|
Quinolone dispersions. Provided are new ophthalmologically suitable pharmaceutical compositions c... |
|
|
Invention
|
Bromfenac, prednisolone, and moxifloxacin compositions and methods. Provided here are new ophthal... |
|
|
Invention
|
Triamcinolone and moxifloxacin compositions. Provided here are new ophthalmologically suitable ph... |
|
|
Invention
|
Gatifloxacin, prednisolone, and bromfenac compositions and methods. Provided here are new ophthal... |
|
|
Invention
|
Loteprednol and moxifloxacin compositions and methods. Provided here are new ophthalmologically s... |
|
|
Invention
|
Prednisolone and moxifloxacin compositions and methods. Provided here are new ophthalmologically ... |
|
|
Invention
|
Trimcinolone and moxifloxacin methods. Provided here are new ophthalmological methods for the tre... |
|
|
Invention
|
Epinephrine parenteral formulations.
The present invention relates to liquid formulations of epi... |
|
|
Invention
|
Liquid ready-to-use formulation of levothyroxine. The present invention relates to liquid formula... |
|
|
Invention
|
Methods of treating eye disease with tobramycin-related compositions. Disclosed herein are method... |
|
|
Invention
|
Combination products of tobramycin compounds and dexameihasone compounds. Disclosed herein are ne... |
|
|
Invention
|
Tobramycin compound conjugates and derivative compositions. Disclosed herein are compositions com... |
|
|
Invention
|
Cetirizine ophthalmic compositions.
The present invention relates to an ophthalmic composition c... |
